These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33210895)

  • 1. [Aspirin-exacerbated respiratory disease: current diagnosis and treatment].
    He SC; Xu YT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Nov; 55(11):1091-1094. PubMed ID: 33210895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin-sensitive asthma and upper airway diseases.
    Chang JE; Chin W; Simon R
    Am J Rhinol Allergy; 2012; 26(1):27-30. PubMed ID: 22391075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin-exacerbated respiratory disease: personalized medical and surgical approaches.
    Schlosser RJ
    Int Forum Allergy Rhinol; 2020 Sep; 10(9):1035-1036. PubMed ID: 32634286
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
    Simon RA; Dazy KM; Waldram JD
    Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease.
    Pelletier T; Roizen G; Ren Z; Hudes G; Rosenstreich D; Jerschow E
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1319-1321. PubMed ID: 30144584
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease.
    Pitlick MM; Pongdee T
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2187-2190.e1. PubMed ID: 35598867
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin-exacerbated respiratory disease: not always "adult-onset".
    Tuttle KL; Schneider TR; Henrickson SE; Morris D; Abonia JP; Spergel JM; Laidlaw TM
    J Allergy Clin Immunol Pract; 2016; 4(4):756-8. PubMed ID: 27393784
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin-Exacerbated Respiratory Disease: A Unique Case of Drug Hypersensitivity.
    Corey KB; Cahill KN
    Immunol Allergy Clin North Am; 2022 May; 42(2):421-432. PubMed ID: 35469627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization.
    White AA; Stevenson DD
    Semin Respir Crit Care Med; 2012 Dec; 33(6):588-94. PubMed ID: 23047310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Waldram JD; Simon RA
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):693-703. PubMed ID: 27712764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.
    Cho KS; Soudry E; Psaltis AJ; Nadeau KC; McGhee SA; Nayak JV; Hwang PH
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):575-81. PubMed ID: 25118195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
    DeGregorio GA; Singer J; Cahill KN; Laidlaw T
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 in a series of patients with aspirin-exacerbated respiratory disease.
    White AA; Cahill KN; Jerschow E; Kuruvilla M; Sehanobish E; Bensko J; Laidlaw TM; Levy JM
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2900-2903. PubMed ID: 33965591
    [No Abstract]   [Full Text] [Related]  

  • 16. A retrospective analysis of bronchiectasis in patients with aspirin-exacerbated respiratory disease.
    Chen YS; Bensko JC; Laidlaw TM; Buchheit KM
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2799-2801. PubMed ID: 32330669
    [No Abstract]   [Full Text] [Related]  

  • 17. Multidisciplinary single-center outcomes compared to two-center outcomes for the treatment of aspirin exacerbated respiratory disease.
    Bosso JV; Tripathi SH; Kennedy DW; Kohanski MA; Cohen NA; Palmer JN; Adappa ND
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2498-2500. PubMed ID: 33548515
    [No Abstract]   [Full Text] [Related]  

  • 18. A retrospective analysis of esophageal eosinophilia in patients with aspirin-exacerbated respiratory disease.
    Eid RC; Palumbo ML; Laidlaw TM; Buchheit KM; Cahill KN
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1338-1340. PubMed ID: 30261317
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease.
    Hill J; Burnett T; Katial R
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):735-747. PubMed ID: 27712767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases].
    Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A
    Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.